Study the Glucose Transport, Angiogenesis and Apoptosis Behavioral through Chemotherapy Treatment According to Receptors Status in Women with Breast Cancer
DOI:
https://doi.org/10.37506/ijfmt.v14i3.10822Keywords:
Breast cancer, glucose transport, angiogenesis, apoptosis.Abstract
Background: Glucose transporting into cells, angiogenesis, and apoptosis are the main factors that inducing
the progression of many types of cancers including breast cancer. BC progression was seen as a multi-step
process involving progressive changes from normal to hyperplasia with and without atypia, carcinoma in
situ, invasive carcinoma, and metastasis.
Aim: Assessment the role of glucose transport-1 (GLUT-1), vascular endothelial growth factor (VEGF),
and cluster of differentiation factor(CD44) as a glucose transporting into cells, angiogenesis, and apoptotic
factors in women with BC whom receiving chemotherapy.
Method and Subjects: 120 women with BC included in this study as a patients group as well as 120
apparently healthy women as control. The women with BC is divided into sub-groups depending on
chemotherapy treatment status. GLUT-1, VEGF, and CD44 were investigated by ELISA method.
Results: This study suggested that highly significant differences in the mean and standard division of GLUT?1
and VEGF in all cases of women with BC compare to control group (P-Value< 0.05). The levels of GLUT?1
was highly significant difference between two subgroup have Her?2 positive and negative (p < 0.001), and
the levels of VEGF, and CD44 in patients subgroups were significant (p< 0.05).
Conclusion: The following up of the progression and responding to chemotherapy treatment may be more
easy by estimation the glucose transporting, angiogenesis, and apoptotic markers in women with BC.
Downloads
Published
Issue
Section
License
https://creativecommons.org/licenses/by-nc/2.0/deed.en